Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Intimation Of Board Meeting In Compliance With Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements), 2015

 We wish to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, July 25, 2017 at the Administrative Office of the Company at Mumbai at 4:00 P.M. 1. To consider various options to raise funds, including issue of Equity shares / Warrants on preferential basis, pursuant to applicable provisions of the Companies Act, 2013 along with applicable SEBI (LODR) Regulations, 2015, SEBI (ICDR) Regulations, 2009, as updated from time to time....
20-07-2017
Bigul

Intimation Of Board Meeting In Compliance With Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements), 2015

 We wish to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, July 25, 2017 at the Administrative Office of the Company at Mumbai at 4:00 P.M. 1. To consider various options to raise funds, including issue of Equity shares / Warrants on preferential basis, pursuant to applicable provisions of the Companies Act, 2013 along with applicable SEBI (LODR) Regulations, 2015, SEBI (ICDR) Regulations, 2009, as updated from time to time....
20-07-2017
Bigul

Shareholding for the Period Ended June 30, 2017

 Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
19-07-2017
Bigul

Annual report for Kilitch Drugs(I) Ltd. for FY-2017
31-05-2017
Bigul

Financial Results For Year Ended 31/03/2017

 With the reference to the above captioned subject, we wish to intimate your esteemed exchange that as decided in the Meeting of the Board of Directors of the Company held on today, i.e. Tuesday, May 30, 2017, for which intimation was already given to you, the Board of Directors has: Approved and taken on record the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2017 along with the Auditors Report thereon.
30-05-2017
Bigul

Closure of Trading Window

 pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the year ended March 31, 2017 from May 10, 2017 to June 01, 2017
10-05-2017
Bigul

Board Meeting On Tuesday, 30Th May, 2017

 We wish to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 30th May 2017 at the Administrative Office of the Company at Mumbai at 4.00 P.M.: To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017; Any other matter with the permission of the Chair. Further, pursuant to the Securities and Exchange...
10-05-2017
Bigul

Certificate Under Regulation 40(9) For The Half Year Ended March 31, 2017.

 we are enclosing herewith Certificate under Regulation 40(9) as received from a Company Secretary in Whole-time in Practice for the half year ended March 31, 2017.
27-04-2017
Bigul

Shareholding for the Period Ended March 31, 2017

 Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
20-04-2017
Bigul

Compliance Certificate For The Period Ended 31.03.2017

 Compliance certificate for the period ended 31.03.2017
20-04-2017
Next Page
Close

Let's Open Free Demat Account